LEAF™ Purified anti-mouse SCF Antibody, SCF, Poly5417,BioLegend,541703

This antibody has not been tested for ICC.

Host

Goat

Reactivity

Mouse

Application

Block - Quality testedWB - Verified

Platform ID

BAB811912148

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameLEAF™ Purified anti-mouse SCF Antibody, SCF, Poly5417
Cat. No.541703
HostGoat
RRIDAB_2936595 (BioLegend Cat. No. 541703)
IsotypeGoat Polyclonal IgG
ReactivityMouse
ApplicationBlock - Quality testedWB - Verified
ClonalityPolyclonal
Clone NumberPoly5417
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetSCF
ImmunogenRecombinant mouse SCF
PurityThe LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
Formulation0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
StorageUpon receipt, store frozen at -20°C. Make small volume aliquots if needed and avoid repeated freeze-thaw cycles to prevent denaturing the antibody.
Regulatory StatusResearch Use Only

Scientific Background

SCF (KITL) is a hematopoietic growth factor, and it can synergize with a number of other cytokines to stimulate growth of hematopoietic progenitors in vitro and stimulates blood cell productionin vivo. SCF is encoded by Sl ('steel'), a gene critical to the development of several distinct cell lineages during embryonic life. Even though KITL was identified as a soluble protein, the predicted amino acid sequence indicates that it is an integral transmembrane protein. KITL is generated by proteolytic cleavage from a transmembrane precursor. Two splice variants have been described for KITL, and proteolytic processing of both transmembrane protein products occurs on the cell surface. The binding of KITL induces the dimerization of the KIT molecule, followed by a change in the configuration of the intracellular domain and the autophosphorylation of the receptor, opening several docking sites for signal transduction molecules. Dysregulation of SCF–KI signaling and gain-of-function KIT mutations contribute to the genesis of many cancers, like acute myeloid leukemia and gastrointestinal stromal tumors.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.